Diagnostics is pleased to announce the launch of our first-in class NGAL Monkey antibody portfolio
The launch of NGAL Monkey antibodies is yet another step in our continued efforts to raise the focus on nephrotoxicity in drug discovery, and it makes our range on kidney related antibodies the most comprehensive on the market.Read more
Sepsis frequently results in acute kidney injury (AKI). Although AKI markedly contributes to mortality in sepsis, its diagnosis is frequently delayed due to limitations of current biomarkers of renal impairment. Neutrophil-gelatinase-associated lipocalin (NGAL) has been demonstrated to be a biomarker of early AKI.
To download as pdf please click hereRead more